Crossject
Develops emergency medications delivered via a needle-free auto-injector platform.
ALCJ | PA
Overview
Corporate Details
- ISIN(s):
- FR0004178614 (+6 more)
- LEI:
- 969500W1VTFNL2D85A65
- Country:
- France
- Address:
- 6 Rue Pauline Kergomard, 21000 dijon
- Website:
- https://www.crossject.com/en
- Sector:
- Manufacturing
Description
Crossject is a specialty pharmaceutical company focused on developing and commercializing medications for life-threatening emergency situations. The company's core technology is ZENEO®, a proprietary, pre-filled, single-use needle-free auto-injector. This platform is designed to enable patients or untrained caregivers to rapidly, safely, and reliably administer emergency treatments. Crossject's product pipeline targets critical conditions such as epileptic seizures, acute adrenal crisis, and severe allergic reactions (anaphylaxis), aiming to improve patient outcomes by simplifying drug delivery in urgent scenarios.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-05-16 18:31 |
Crossject : Information relative au nombre total de droits de vote et d’actions…
|
French | 127.3 KB | ||
| 2022-05-03 19:18 |
CROSSJECT : Point d'information
|
French | 118.8 KB | ||
| 2022-03-24 20:22 |
CROSSJECT : Résultats annuel 2021 - Premiers dépôts d'AMM attendus en 2023
|
French | 243.3 KB | ||
| 2022-03-21 07:30 |
CROSSJECT : Conformité du premier lot de transposition industrielle de ZENEO® H…
|
French | 135.0 KB | ||
| 2022-02-11 19:15 |
Crossject : Calendrier financier 2022
|
French | 122.7 KB | ||
| 2022-01-17 19:59 |
Crossject : Mise en œuvre du contrat de liquidité conclu avec Invest Securities
|
French | 88.1 KB | ||
| 2022-01-17 19:53 |
Crossject :Bilan de fin de contrat de liquidité conclu avec Kepler Cheuvreux
|
French | 92.6 KB | ||
| 2022-01-06 18:05 |
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
French | 127.4 KB | ||
| 2022-01-04 19:11 |
Crossject : Calendrier détaillé de l’attribution gratuite des bons de souscript…
|
French | 194.3 KB | ||
| 2021-12-15 19:23 |
Crossject renforce ses moyens de financement et associe l'ensemble de ses actio…
|
French | 200.5 KB | ||
| 2021-12-13 18:21 |
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
French | 127.3 KB | ||
| 2021-12-02 19:52 |
Crossject : Validation du lot clinique ZENEO® Midazolam
|
French | 93.7 KB | ||
| 2021-11-16 17:55 |
Crossject : Certificat Bonnes Pratiques de Fabrication délivré par L'ANSM
|
French | 130.5 KB | ||
| 2021-09-22 18:13 |
Crossject : Résultats du premier semestre 2021 et point d'activité
|
French | 221.6 KB | ||
| 2021-09-09 20:11 |
Crossject : Descriptif du programme de rachat d'actions 2021-2022
|
French | 93.8 KB |
Automate Your Workflow. Get a real-time feed of all Crossject filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Crossject
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Crossject via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-06-24 | N/A | Other | Buy | 20,000 | N/A |
| 2024-06-14 | N/A | Other | Other | 10,979 | 20,289.19 EUR |
| 2024-06-06 | N/A | Other | Other | 1,058,617 | 1,956,324.22 EUR |
| 2024-06-06 | N/A | Other | Other | 16,106 | 29,763.89 EUR |
| 2024-06-06 | N/A | Other | Other | 10,275 | 18,988.20 EUR |
| 2024-06-06 | N/A | Other | Other | 10,074 | 18,616.75 EUR |
| 2024-06-06 | N/A | Other | Buy | 5,536 | 10,230.53 EUR |
| 2023-03-06 | N/A | Other | Other | 22,859 | 75,434.70 EUR |
Peer Companies
